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Cholangiocarcinoma (CCA) represents a particular type of liver cancer originating 
from the epithelial cells lining the intrahepatic and extrahepatic biliary tree. It is often 
clinically silent until it becomes an advanced disease with obstructive symptoms and 
a poor prognosis for patients [1]. In this context, searching for alternative therapeutic 
strategies becomes a pivotal goal in the battle against liver cancer. In present research, 
β-caryophyllene (CRY) and β -caryophyllene oxide (CRYO), two natural sesquiterpe-
nes with protective properties [2], have been investigated for their ability to inhibit the 
growth of the human Mz-ChA-1 cholangiocarcinoma cells from extrahepatic bile ducts 
and the H69 non-malignant cholagiocytes. The cells were exposed to the test com-
pounds for 24 h, then the cytotoxicity was measured by MTT assay [3]; doxorubicin was 
included as a standard cytotoxic agents. Both sesquiterpenes reduced the cholangiocytes 
proliferation. Particularly, CRY produced a marked cytotoxicity in the Mz-ChA-1cells 
at concentrations lower than that required for CRYO. Surprisingly, the antiproliferative 
effects produced by both CRY and CRYO were higher than that of the standard doxoru-
bicin. In the non-malignant cholangiocytes, in spite of a low cytotoxicity of CRYO, CRY 
reduced the cell proliferation already at lower concentrations, acting in a similar way to 
doxorubicin. Being CRYO an epoxide analogue of CRY, the different cytotoxicity found 
could be due to their structural features and bioavailability. Present results encourage 
further studies on CRY and CRYO as chemopreventive agents for cholangiocarcinoma.
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